0001751806-26-000003.txt : 20260424 0001751806-26-000003.hdr.sgml : 20260424 20260424165914 ACCESSION NUMBER: 0001751806-26-000003 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260424 DATE AS OF CHANGE: 20260424 EFFECTIVENESS DATE: 20260424 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Life Biosciences LLC CENTRAL INDEX KEY: 0001751806 ORGANIZATION NAME: EIN: 822142145 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-581853 FILM NUMBER: 26895390 BUSINESS ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: THIRD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 2062185982 MAIL ADDRESS: STREET 1: 75 PARK PLAZA STREET 2: THIRD FLOOR CITY: BOSTON STATE: MA ZIP: 02116 D 1 primary_doc.xml X0708 D LIVE 0001751806 Life Biosciences LLC 75 PARK PLAZA THIRD FLOOR BOSTON MA MASSACHUSETTS 02116 (857) 400-9245 DELAWARE None None Limited Liability Company true Gerald McLaughlin 75 Park Plaza Third Floor Boston MA MASSACHUSETTS 02116 Executive Officer Director Sharon Rosenzweig-Lipson 75 Park Plaza Third Floor Boston MA MASSACHUSETTS 02116 Executive Officer Michael Ringel 75 Park Plaza Third Floor Boston MA MASSACHUSETTS 02116 Executive Officer Amit Shashank 75 Park Plaza Third Floor Boston MA MASSACHUSETTS 02116 Executive Officer Ilan Stern 75 Park Plaza Third Floor Boston MA MASSACHUSETTS 02116 Director David Sinclair 75 Park Plaza Third Floor Boston MA MASSACHUSETTS 02116 Director Stuart Gibson 75 Park Plaza Third Floor Boston MA MASSACHUSETTS 02116 Director David Guyer 75 Park Plaza Third Floor Boston MA MASSACHUSETTS 02116 Director Other Decline to Disclose 06b false 2025-11-25 false true false 0 Chatsworth Securities LLC 40804 None None 95 East Putnam Avenue Greenwich CT CONNECTICUT 06830 CA CALIFORNIA MA MASSACHUSETTS NY NEW YORK false 31000002 31000002 0 In addition to the foregoing amount, the Issuer previously sold securities totaling $48,999,995 in the financing pursuant to Section 4(a)(2) of the Securities Act of 1933, as amended. false 8 0 30000 0 false Life Biosciences LLC /s/ Amit Shashank Amit Shashank Chief Administrative Officer, General Counsel & Secretary 2026-04-24